Catherine Heffernan
Market Analysis of Vaccines This statistic displays the top 5 global vaccine products based on their revenues worldwide in 2014, and a projection for 2020. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate 5.8 billion U.S. dollars in revenues by 2020. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Comparte este artículo
English 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 